Expanding the immunocompromised patient care area.
Official title: WORK ORDER 126643 B539 EXPAND IC SUITE
Funded at Leidos Biomedical Research, INC. · NIH-11219241 · Data updated 2026-11-12
This study is working to make a bigger and better space for patients with weakened immune systems, so they can receive care in a more comfortable and accessible environment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project start | July 11, 2024 |
| Project end | February 25, 2026 |
| Funding year | 2024 |
| Award (this year) | $461,187 |
| NIH project number | 75N91019D00024-0-759102400026-1 |
| Project ID | NIH-11219241 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients who are immunocompromised or immunosuppressed and require specialized medical care.
✕Less likely to help
Patients who are not immunocompromised or do not require specialized care in an IC suite may not benefit from this research.
What this research studies
This project aims to enhance the facilities available for immunocompromised patients by expanding the existing Immunocompromise (IC) suite. The expansion involves combining two rooms to create a larger, more accessible space for healthcare staff and patients. This will allow for the addition of new equipment and improve the overall environment for patient care. By increasing the capacity and functionality of the IC suite, the project seeks to better accommodate the needs of patients who are immunosuppressed.
Why it matters
Potential benefit: If successful, this expansion could lead to improved care and outcomes for immunocompromised patients by providing a more suitable environment for their treatment.
How similar studies have gone: While this specific project focuses on facility expansion, similar initiatives in enhancing patient care environments have shown positive outcomes in improving patient experiences and treatment efficacy.
Where this research is happening
-
Leidos Biomedical Research, INC.
Frederick, United States Active
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
Related research
Other NIH-funded projects on the same topics.
-
Improving public health responses to COVID-19 through standardized testing.
This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.
-
Creating a large library of cancer models for research use
This study is creating a collection of new cancer models to help researchers and companies find better ways to treat cancer, making it easier for everyone to work together and share ideas.
-
Advancing global cancer control through data analysis and international collaboration
This study is all about helping countries around the world work better together to fight cancer by sharing important information and training scientists, especially in places that need extra support.
-
Support for HIV and HPV cancer prevention clinical trials in the Americas
This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.
-
Development and production of clinical-grade biopharmaceuticals
This study is all about making safe and effective new medicines, like vaccines and treatments for various conditions, so that patients can have access to the latest therapies that meet high-quality standards.
-
Understanding the immune response to COVID-19
This study is looking for ways to improve COVID-19 testing and understand how our immune system fights the virus, and you can help by sharing samples to make these tests better for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.